Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer’s Disease

Abstract

Background: Blood plasma proteins have been associated with Alzheimer’s disease (AD), but understanding which proteins are on the causal pathway remains challenging. Objective: Investigate the genetic overlap between candidate proteins and AD using polygenic risk scores (PRS) and interrogate their causal relationship using bi-directional Mendelian randomization (MR). Methods: Following a literature review, 31 proteins were selected for PRS analysis. PRS were constructed for prioritized proteins with and without the apolipoprotein E region (APOE+/–PRS) and tested for association with AD status across three cohorts (n = 6,244). An AD PRS was also tested for association with protein levels in one cohort (n = 410). Proteins showing association with AD were taken forward for MR. Results: For APOE ɛ3, apolipoprotein B-100, and C-reactive protein (CRP), protein APOE+ PRS were associated with AD below Bonferroni significance (pBonf, p < 0.00017). No protein APOE- PRS or AD PRS (APOE+/–) passed pBonf. However, vitamin D-binding protein (protein PRS APOE-, p = 0.009) and insulin-like growth factor-binding protein 2 (AD APOE- PRS p = 0.025, protein APOE- PRS p = 0.045) displayed suggestive signals and were selected for MR. In bi-directional MR, none of the five proteins demonstrated a causal association (p < 0.05) in either direction. Conclusion: Apolipoproteins and CRP PRS are associated with AD and provide a genetic signal linked to a specific, accessible risk factor. While evidence of causality was limited, this study was conducted in a moderate sample size and provides a framework for larger samples with greater statistical power.

Vitamin D binding protein in psychiatric and neurological disorders: Implications for diagnosis and treatment

“…The correlation between VDBP polymorphisms and AD is a subject of continuous investigation and the results have shown discrepancies across different research studies. 69 The existence of alterations in the VDBP levels in the blood or the CSF of individuals with AD is unclear. Several research studies indicated that the concentration of VDBP in their blood plasma was notably elevated in comparison to that of controls, 70 , 71 and serum VDBP levels have a strong positive correlation with a latent dementia phenotype.…”

BCG Vaccine—The Road Not Taken

“…Accumulating data suggest a critical role played by the immune system in neurodegenerative Alzheimer’s and Parkinson’s diseases [ 71 ]. Exposure to BCG in elderly adults showed 58% reduced risk of developing AD and 28% reduced risk of developing PD [ 72 ].…”